Evidence map›Paper›PMID 38191997›Full record

ArticleJournal of chemical information and modeling2024

Docking for Molecules That Bind in a Symmetric Stack with SymDOCK.

Matthew S Smith, Ian S Knight, Rian C Kormos, Joseph G Pepe, Peter Kunach, Marc I Diamond, Sarah H Shahmoradian, John J Irwin, William F DeGrado, Brian K Shoichet

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. In-depth multimodal validation ofExperimental & molecular medicine · 2026
    Article
  2. Article
  3. A Cooperative Model for Symmetric Ligand Binding to Protein Fibrils.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Matthew S SmithDepartment of Pharmaceutical Chemistry, University of California, UCSF Genentech Hall Box 2280, 600 16th St Rm 518,San Francisco, California 94158, United States.
Ian S KnightDepartment of Pharmaceutical Chemistry, University of California, UCSF Genentech Hall Box 2280, 600 16th St Rm 518,San Francisco, California 94158, United States.
Rian C KormosDepartment of Pharmaceutical Chemistry, University of California, UCSF Genentech Hall Box 2280, 600 16th St Rm 518,San Francisco, California 94158, United States.
Joseph G PepeDepartment of Pharmaceutical Chemistry, University of California, UCSF Genentech Hall Box 2280, 600 16th St Rm 518,San Francisco, California 94158, United States.
Peter KunachMcGill Research Centre for Studies in Aging, McGill University, 6875 Boulevard LaSalle, Montreal, Quebec H4H 1R3, Canada.
Marc I DiamondCenter for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, 6124 Harry Hines Blvd. Suite NS03.200, Dallas, Texas 75390, United States.
Sarah H ShahmoradianCenter for Alzheimer's and Neurodegenerative Diseases, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, 6124 Harry Hines Blvd. Suite NS03.200, Dallas, Texas 75390, United States.
John J IrwinDepartment of Pharmaceutical Chemistry, University of California, UCSF Genentech Hall Box 2280, 600 16th St Rm 518,San Francisco, California 94158, United States.
William F DeGradoDepartment of Pharmaceutical Chemistry, University of California, UCSF Genentech Hall Box 2280, 600 16th St Rm 518,San Francisco, California 94158, United States.
Brian K ShoichetDepartment of Pharmaceutical Chemistry, University of California, UCSF Genentech Hall Box 2280, 600 16th St Rm 518,San Francisco, California 94158, United States.ORCID 0000-0002-6098-7367

Funding

VIRAL DEGENERATIVE DEMENTING DISEASE IN AGING (SUPP)P01AG002132 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SALI, ANDREJ · 1985 to 2024
$51.7M
Development and Testing of New Computational Methods for Ligand Discovery and MechanismR35GM122481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Brian K Shoichet · 2017 to 2026
$8.5M
Deciphering the relationship between structure, dynamics and function in helical bundle proteinsR35GM122603 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WILLIAM DEGRADO · 2017 to 2026
$7.1M
Molecular Details of Psychoactive Drug ActionsR01MH112205 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Bryan L. Roth, Brian K Shoichet · 2017 to 2026
$6.1M
Mechanistic insights into LSD actions at 5-HT2A serotonin receptorsR37DA045657 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Bryan L. Roth · 2018 to 2026
$5.8M
Seeds and Strains Derived from Tau Monomer - Perez Diversity SupplementRF1AG065407 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI DIAMOND, MARC I, JOACHIMIAK, LUKASZ A. · 2020 to 2021
$3.2M
Molecular Biophysics Training GrantT32GM149436 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Aashish Manglik · 2023 to 2026
$1.6M
Cellular Anatomy of Tau SeedingR21AG080497 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI SHAHMORADIAN, SARAH H · 2023 to 2024
$451k
NIA NIH HHS P01 AG002132NIA NIH HHS R21 AG080497NIA NIH HHS RF1 AG065407NIDA NIH HHS R37 DA045657NIGMS NIH HHS R35 GM122481NIGMS NIH HHS R35 GM122603NIGMS NIH HHS T32 GM149436NIMH NIH HHS R01 MH112205
6 · The paper itself

Abstract

Discovering ligands for amyloid fibrils, such as those formed by the tau protein, is an area of great current interest. In recent structures, ligands bind in stacks in the tau fibrils to reflect the rotational and translational symmetry of the fibril itself; in these structures, the ligands make few interactions with the protein but interact extensively with each other. To exploit this symmetry and stacking, we developed SymDOCK, a method to dock molecules that follow the protein's symmetry. For each prospective ligand pose, we apply the symmetry operation of the fibril to generate a self-interacting and fibril-interacting stack, checking that doing so will not cause a clash between the original molecule and its image. Absent a clash, we retain that pose and add the ligand-ligand van der Waals energy to the ligand's docking score (here using DOCK3.8). We can check these geometries and energies using an implementation of ANI, a neural-network-based quantum-mechanical evaluation of the ligand stacking energies. In retrospective calculations, symmetry docking can reproduce the poses of three tau PET tracers whose structures have been determined. More convincingly, in a

Indexed as

ProteinsBinding SitesLigandsMolecular Docking SimulationProspective StudiesProtein BindingRetrospective StudiesLigandsProteins

Identifiers

PMID38191997
PMCPMC10806807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.